Incidence rate of small cell lung cancer with hyponatremia and analysis of treatment method

刘　涵; 李峻岭

doi:10.3969/j.issn.1007-3969.2015.12.014

您当前的位置：

首页 >

文章列表页 >

Incidence rate of small cell lung cancer with hyponatremia and analysis of treatment method

更新时间：2025-12-31

- Incidence rate of small cell lung cancer with hyponatremia and analysis of treatment method
- China Oncology Vol. 25, Issue 12, Pages: 999-1000(2015)
- 作者机构：
  
  1. 北京协和医学院中国医学科学院肿瘤医院肿瘤内科,北京,100021
  2. 首都医科大学附属复兴医院肿瘤内科,北京,100038
- 作者简介：
- 基金信息：
- DOI：10.3969/j.issn.1007-3969.2015.12.014
  CLC：
- Published Online：03 February 2016，
  
  Published：03 February 2015
- 稿件说明：
移动端阅览
刘　涵,李峻岭. 小细胞肺癌合并低钠血症的发生率调查及治疗方法分析[J]. 中国癌症杂志, 2015, 25(12): 999-1000.

刘　涵, 李峻岭. Incidence rate of small cell lung cancer with hyponatremia and analysis of treatment method[J]. China Oncology, 2015, 25(12): 999-1000.
刘　涵,李峻岭. 小细胞肺癌合并低钠血症的发生率调查及治疗方法分析[J]. 中国癌症杂志, 2015, 25(12): 999-1000. DOI： 10.3969/j.issn.1007-3969.2015.12.014.

刘　涵, 李峻岭. Incidence rate of small cell lung cancer with hyponatremia and analysis of treatment method[J]. China Oncology, 2015, 25(12): 999-1000. DOI： 10.3969/j.issn.1007-3969.2015.12.014.

摘要

Abstract

关键词

Keywords

references

Views

3649

下载量

CSCD

Alert me when the article has been cited

提交

Tools

Publicity Resources

Guidelines for breast cancer diagnosis and treatment by China Anti-Cancer Association (2026 edition)

Expert consensus on diagnosis and treatment of hematologic malignancies with solid tumors (2025 version)

MITF expression in acral melanoma tissues and its association with clinical, pathological characteristics and prognosis

Analysis of clinical features, prognosis and comprehensive therapeutic strategies in 261 patients with limited-stage esophageal small cell carcinoma

Research progress on treatment of pleural effusion related to immune checkpoint inhibitors

Related Author

The Society of Breast Cancer China Anti-Cancer Association

Breast Oncology Group of the Oncology Branch of the Chinese Medical Association

Multiple Primary and Unknown Primary Tumors Special Committee of China Anti-Cancer Association

Shanghai Anti Cancer Association Multiple Primary and Unknown Primary Tumor Special Committee

Lymphocytic Disease Group, Hematology Branch, Chinese Medical Association

Rare Disease Group, Hematology Branch, Chinese Medical Association

Tong WANG

Wei SUN

Related Institution

Department of Musculoskeletal Oncology, Fudan University Shanghai Cancer Center; Department of Oncology, Shanghai Medical College, Fudan University

Department of Thoracic Surgery, Fudan University Shanghai Cancer Center, State Key Laboratory of Genetic Engineering, Fudan University, Institute of Thoracic Oncology, Fudan University, Department of Oncology, Shanghai Medical College, Fudan University

Department of Radiation Oncology, Fudan University Shanghai Cancer Center, Shanghai Key Laboratory of Radiation Oncology, Shanghai Clinical Research Center for Radiation Oncology, Department of Oncology, Shanghai Medical College, Fudan University

Clinical Oncology Center, Shanghai Municipal Hospital of Traditional Chinese Medicine, Shanghai University of Traditional Chinese Medicine, Institute of Oncology, Shanghai Municipal Hospital of Traditional Chinese Medicine, Shanghai University of Traditional Chinese Medicine

Department of Oncology, The First Affiliated Hospital of Zhengzhou University

AI问答

⁰